Liver Diseases  >>  dabigatran etexilate  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dabigatran etexilate / Generic mfg.
NCT02170571: Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate in Patients With Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Completed
1
24
Europe
Dabigatran etexilate
Boehringer Ingelheim
Hepatic Insufficiency
12/05
 

Download Options